S Kagiyama
Overview
Explore the profile of S Kagiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takata Y, Ansai T, Soh I, Kimura Y, Yoshitake Y, Sonoki K, et al.
Gerontology
. 2008 May;
54(6):354-60.
PMID: 18460865
Background: Little is known about the association between physical fitness and cognitive function in very elderly people (over 80 years of age). Objectives: To evaluate that relationship in 85-year-old community-dwelling...
2.
Role of percutaneous transhepatic obliteration for special types of varices with portal hypertension
Chikamori F, Kuniyoshi N, Kagiyama S, Kawashima T, Shibuya S, Takase Y
Abdom Imaging
. 2006 Jun;
32(1):92-5.
PMID: 16802200
The treatment of special types of varices with portal hypertension has not yet been established. We were able to control 13 cases of special types of varices by percutaneous transhepatic...
3.
Kagiyama S, Tsuchihashi T, Phillips M, Abe I, Matsumura K, Fujishima M
J Hypertens
. 2001 Nov;
19(12):2213-9.
PMID: 11725166
Objective: Magnesium sulfate (MgSO4) is widely used for the treatment of eclampsia. However, effects of Mg2+ in central cardiovascular regulation remain unclear. In the present study, the role of Mg2+...
4.
Fujishima S, Ohya Y, Sugimori H, Kitayama J, Kagiyama S, Ibayashi S, et al.
Hypertens Res
. 2001 Aug;
24(4):345-51.
PMID: 11510745
To appraise the value of transcranial Doppler sonography (TCD) for assessment of hypertensive cerebrovascular damage, the relationship between ambulatory blood pressure (BP) and indices of cerebral circulation determined by TCD...
5.
Kagiyama S, Kagiyama T, Phillips M
Curr Opin Mol Ther
. 2001 Aug;
3(3):258-64.
PMID: 11497350
Many kinds of drugs are used for the treatment of hypertension, but they are all short-acting (< or = 24 h) and patient compliance is poor. Gene therapy offers the...
6.
Ohya Y, Sasaki M, Fujishima S, Kagiyama S, Onaka U, Kaseda S, et al.
Clin Exp Hypertens
. 2001 May;
23(4):293-304.
PMID: 11349821
Iodine-123 metaiodobenzylguanidine (MIBG) myocardial imaging is considered to reflect cardiac sympathetic function. We performed myocardial MIBG scintigraphy and echocardiography in 27 patients with essential hypertension (EHT), 7 patients with renovascular...
7.
Lin Y, Tsuchihashi T, Kagiyama S, Matsumura K, Abe I
Hypertens Res
. 2001 Apr;
24(2):173-8.
PMID: 11325077
Unlabelled: We examined the influence of chronic antihypertensive treatment on the central pressor response in SHR. Adult male SHR were divided into 5 groups, i.e., those receiving 1) enalapril (Enal:...
8.
Kagiyama S, Varela A, Phillips M, Galli S
Hypertension
. 2001 Mar;
37(2 Pt 2):371-5.
PMID: 11230302
The systemic renin-angiotensin system (RAS) plays an important role in blood pressure (BP) regulation during the development of 2-kidney, 1 clip (2K1C) hypertension. Its contributions decrease with time after constriction...
9.
Schmidt-Ott K, Kagiyama S, Phillips M
Regul Pept
. 2000 Oct;
93(1-3):65-77.
PMID: 11033054
Angiotensin II (Ang II), the effector peptide of the renin-angiotensin system, has been implied in the pathogenesis of atherosclerosis on various levels. There is abundant experimental evidence that pharmacological antagonism...
10.
Tsuchihashi T, Kagiyama S, Matsumura K, Lin Y, Abe I, Fujishima M
Hypertens Res
. 2000 Jul;
23(4):359-64.
PMID: 10912773
It has been suggested that nitric oxide (NO) influences the actions of L-glutamate and angiotensin II in the brain. In the present study, we examined whether cardiovascular responses to L-glutamate...